Clinerion and Datametrix Discuss Improving the Oncology Drug Development Pipeline Using RWE

Clinerion partnered with Datametrix to better understand how to develop synthetic control arms using real world evidence (RWE). Notably, researchers were able to recapitulate findings from randomized controlled trials using electronic medical record (EMR) data.

“Can real world data support drug development with better trial design and real-world evidence? Our collaboration with Datametrix has uncovered how use of statistical analytics methodologies on electronic health records can build synthetic control arms to supplement clinical trial data for better clinical and regulatory decisions.” Read more here.

(Source: Clinerion, 2021)